Document Detail


Cardiomyoplasty as an isolated procedure to treat refractory heart failure.
MedLine Citation:
PMID:  9080169     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
OBJECTIVE: Cardiomyoplasty represents a controversial therapy for chronic heart failure. The aim of this study is to review our experience of such a surgical procedure as an isolate approach to treat refractory left ventricular dysfunction. METHODS: Twenty-two patients were considered candidates for cardiomyoplasty because of chronic heart failure. Mean age was 58.7 +/- 5.3 (range 48-71 years), 19 patients were male and 3 were female. Ischemic or idiopathic etiology was present in 11 cases, respectively. Traditional as well as innovative techniques were used to assess hemodynamic function. Pre-operative hemodynamic profile included mean left ventricular ejection fraction of 20 +/- 5.8% (9-28%), absence of severe right ventricular failure, and mean left ventricular end-diastolic diameter of 75.5 +/- 7.4 mm (range 61-92 m). All patients were in New York Heart Association Class III or Intermittent IV despite conventional medical therapy. RESULTS: There was no intra-operative death. No additional surgery was performed. Left latissimus dorsi (LD) muscle was used in 20 cases, and right LD in two patients. Early mortality occurred in one patient (low cardiac output syndrome), whereas late mortality in five patients (three sudden deaths, one lung cancer, one heart failure). Mean follow-up is 20.7 +/- 16.7 months (3-51 months). Actuarial survival at 4 years is 70%. Cardiac index increased at 6 months (3.08 +/- 0.5 l/min per m2, P = 0.04), but no other significant changes were observed in the long term (3.03 +/- 0.7 l/min per m2, 3 +/- 0.7 l/min per m2, and 2.85 +/- 0.7 l/min per m2, at 12, 24 and 36 months, respectively). Ejection fraction improved at 6 and 12 months (29.1 +/- 1.03%, P = 0.0017; and 27.3 +/- 5.6%, P = 0.0091, respectively), while no substantial augmentation was documented at 2 and 3 years (25.6 +/- 2.5% and 25.1 +/- 4.0%, respectively). Left ventricular end-diastolic diameter was markedly reduced at 6 (73.2 +/- 8.0 mm, P = 0.0176), 12 (69.4 +/- 8.5 mm, P = 0.002) and 24 months (71.1 +/- 7.0 mm, P = 0.011), and was then stable (74.0 +/- 9.1 mm, P = 0.47) at 36 months. Postoperative pressure/volume loop evaluation showed some improvement of hemodynamic function from skeletal muscle assistance. Acute pulmonary edema episodes, as well as number of hospitalizations, were considerably reduced following cardiomyoplasty. CONCLUSIONS: In our experience, cardiomyoplasty was shown to exert moderate beneficial influence on left ventricular performance, to significantly reduce cardiac dilatation and to promote the stabilization of the disease course.
Authors:
R Lorusso; E Milan; M Volterrani; R Giubbini; F H van der Veen; J J Schreuder; A Picchioni; O Alfieri
Related Documents :
6479129 - Echocardiography in foals from birth to three months old.
3298359 - Comparison of single plane videodensitometry-based right ventricular ejection fraction ...
9369139 - Cardiac function, perfusion, and morbidity in irradiated long-term survivors of hodgkin...
20126339 - Surgical myocardial revascularization of patients with ischemic cardiomyopathy and seve...
1729589 - Volume-outcome relationships and in-hospital mortality: the effect of changes in volume...
477329 - Evaluation of the left ventricular ejection function by means of single beam echocardio...
12473259 - Electrocardiographic measures of left ventricular hypertrophy show greater heritability...
11846859 - Assessment of new onset postcoronary artery bypass surgery atrial fibrillation: current...
25198739 - Beta-blockers in children with duchenne cardiomyopathy.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery     Volume:  11     ISSN:  1010-7940     ISO Abbreviation:  Eur J Cardiothorac Surg     Publication Date:  1997 Feb 
Date Detail:
Created Date:  1997-06-12     Completed Date:  1997-06-12     Revised Date:  2007-11-15    
Medline Journal Info:
Nlm Unique ID:  8804069     Medline TA:  Eur J Cardiothorac Surg     Country:  NETHERLANDS    
Other Details:
Languages:  eng     Pagination:  363-72     Citation Subset:  IM    
Affiliation:
Department of Cardiac Surgery, Ospedale Civile, Brescia, Italy.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Actuarial Analysis
Aged
Cardiomyoplasty / methods*
Female
Follow-Up Studies
Heart Failure / mortality,  physiopathology,  surgery*
Hemodynamics / physiology
Humans
Male
Middle Aged
Postoperative Complications / mortality,  physiopathology
Survival Rate
Treatment Outcome
Ventricular Dysfunction, Left / mortality,  physiopathology,  surgery
Ventricular Function, Left / physiology

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  High cardioplegic perfusion pressure entails reduced myocardial recovery.
Next Document:  Aprotinin in aortic surgery requiring profound hypothermia and circulatory arrest.